Platelet recovery and transfusion needs after reduced intensity conditioning allogeneic peripheral blood stem cell transplantation.

[1]  J. Bussel,et al.  Safety and efficacy of long-term treatment with romiplostim in thrombocytopenic patients with chronic ITP. , 2009, Blood.

[2]  F. Aversa,et al.  Bleeding events and mortality in SCT patients: a retrospective study of hematopoietic SCT patients with organ dysfunctions due to severe sepsis or GVHD , 2009, Bone Marrow Transplantation.

[3]  J. Bussel,et al.  Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, double-blind, placebo-controlled trial , 2009, The Lancet.

[4]  D. Blaise,et al.  Predictive factors and impact of full donor T-cell chimerism after reduced intensity conditioning allogeneic stem cell transplantation. , 2007, Haematologica.

[5]  M. Mohty,et al.  Mechanisms of action of antithymocyte globulin: T-cell depletion and beyond , 2007, Leukemia.

[6]  A. Soubani,et al.  The major autopsy findings in adult patients after hematopoietic stem cell transplantation. , 2007, Annals of transplantation.

[7]  P. Staber,et al.  Severe thrombocytopenia due to host‐derived anti‐HPA‐1a after non‐myeloablative allogeneic haematopoietic stem cell transplantation for multiple myeloma: a case report , 2005, Vox sanguinis.

[8]  B. Coller,et al.  Evidence for megakaryocyte engraftment following reduced-intensity conditioning. , 2004, Experimental hematology.

[9]  R. Bouabdallah,et al.  Decreased RBCTs after reduced intensity conditioning allogeneic stem cell transplantation: predictive value of prior Hb level , 2004, Transfusion.

[10]  D. Blaise,et al.  Reduced-intensity preparative regimen and allogeneic stem cell transplantation for advanced solid tumors. , 2004, Blood.

[11]  D. Olive,et al.  Bone marrow as stem cell source for allogeneic HLA-identical sibling transplantation following reduced-intensity preparative regimen. , 2003, Experimental hematology.

[12]  M. Flowers,et al.  Chronic graft-versus-host disease. , 2003, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[13]  J. Bourhis,et al.  Chronic graft-versus-host disease after allogeneic blood stem cell transplantation: long-term results of a randomized study. , 2002, Blood.

[14]  C. Voena,et al.  Nonmyeloablative conditioning followed by hematopoietic cell allografting and donor lymphocyte infusions for patients with metastatic renal and breast cancer. , 2002, Blood.

[15]  D. Blaise,et al.  Allogeneic hematopoietic stem-cell transplantation after nonmyeloablative preparative regimens: impact of pretransplantation and posttransplantation factors on outcome. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  G. Tjønnfjord,et al.  A randomised study of allogeneic transplantation with stem cells from blood or bone marrow , 2000, Bone Marrow Transplantation.

[17]  J. Bourhis,et al.  Randomized trial of bone marrow versus lenograstim-primed blood cell allogeneic transplantation in patients with early-stage leukemia: a report from the Société Française de Greffe de Moelle. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  A. Nagler,et al.  Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases. , 1998, Blood.

[19]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .